The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...
StockStory.org on MSN
Reflecting on drug development inputs & services stocks’ Q4 earnings: IQVIA (NYSE:IQV)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...
In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...
7don MSN
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its ...
The upcoming FDA decision for Replimune’s advanced melanoma drug could be a litmus test for the agency's future regulatory ...
March 29 (Reuters) - Eli Lilly will sign a $2 billion deal with Hong Kong-listed biotech Insilico Medicine, which uses ...
US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug discovery, highlighting ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: Abivax: ...
Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...
Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for ...
ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results